RAC1 and cancer: CPYPP, a DOCK (dedicator of cytokinesis) inhibitor known for its anti-cancer effects by disrupting the interaction between DOCK2 and Rac1 [24–26], as well as CsA and curcumin, induced significant cytoplasmic vacuolization (Fig. 1A).